Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)
By R. Benza, Dave P. Miller, M. Gomberg-Maitland, R. Frantz, A. Foreman, C. Coffey, A. Frost, R. Barst, D. Badesch, C. Elliott and 2 more. Circulation, 2010
1,535 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/f47deffdd734b91fe8e3625af12486c97303cb25
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Definitions and diagnosis of pulmonary hypertension. (2013, background): “The vast majority of patients diagnosed with IPAH are in World Health Organization functional classes III and IV (37,39–41), which have been shown to predict poorer survival (42,43).”
- A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. (2015, neutral): “65 NYHA Functional Class III, increased mean right atrial pressure, decreased resting systolic blood pressure or an elevated heart rate, decreased 6-minute walk distance, increased brain natriuretic peptide, renal insuf fi ciency, PAH associated with connective tissue diseases, decreased D LCO , and…”
- Pulmonary arterial hypertension (2013, background): “ance >32 Wood units, NYHA functional class IV, men older than 60 years and familiy history of PAH [110].”